Home › Malattie polmonari interstiziali › California
Studi clinici su Malattie polmonari interstiziali nello stato di California
22 studi su Malattie polmonari interstiziali cercano partecipanti presso sedi nello stato di California.
Città nello stato di California
Testo ufficiale dello studio (inglese)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- University of Southern California, Los Angeles
- Newport Native MD, Inc, Newport Beach
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- University of California Los Angeles, Los Angeles
In reclutamentoFase 3
Età 40 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07201922Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA007, Fresno
- USA010, Los Angeles
- USA023, Los Angeles
- e altri 2
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT07179380A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- GSK Investigational Site, Los Angeles
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 set 2026 · NCT06716606A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Orange
- e altri 2
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06572384Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
- San Francisco, San Francisco
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 8 set 2026 · NCT07473700A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
- GSK Investigational Site, Los Angeles
- e altri 1
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT05878717A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of Southern California, Los Angeles
- Cedars Sinai Medical Center, Los Angeles
- Paradigm Clinical Research Centers, LLC, San Diego
In reclutamentoFase 2
Età 40 e oltre · Tutti i sessi · Aggiornato il 4 set 2026 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- HCA Riverside Community Hospital, Riverside
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT06911632A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- David Geffen School of Medicine at UCLA, Los Angeles
- University of California, San Francisco, San Francisco
In reclutamentoFase 3
Età da 18 a 80 · Tutti i sessi · Aggiornato il 2 set 2026 · NCT07285655A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
- Clinical Research Site, Santa Barbara
- Clinical Research Site, Torrance
In reclutamentoFase 2
Età da 18 a 85 · Tutti i sessi · Aggiornato il 2 set 2026 · NCT07333183DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Cedars-Sinai Medical Center, Los Angeles
- UC Davis Health Medical Center, Sacramento
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 26 ago 2026 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- Keck School of Medicine at USC Medical Center, Los Angeles
- Cedars-Sinai Medical Center, Los Angeles
- Stanford University Medical Center, Palo Alto
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 18 ago 2026 · NCT06195072Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of California - Los Angeles, Los Angeles
- University of Southern California, Los Angeles
- Stanford University, Stanford
In reclutamentoStudio osservazionale
Età 21 e oltre · Tutti i sessi · Aggiornato il 12 ago 2026 · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- University of California Davis Health, Rancho Cordova
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 10 ago 2026 · NCT07175038Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
- University of California, San Francisco, San Francisco
In reclutamentoFase 2
Età 4 e oltre · Tutti i sessi · Aggiornato il 22 lug 2026 · NCT04925375Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- Peter Morton Medical Building, Los Angeles
- NewportNativeMD, Inc., Newport Beach
- University of California Irvine Medical Center, Orange
- e altri 4
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 lug 2026 · NCT05943535An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- The Medical Research Group, Inc., Fresno
In reclutamentoStudio osservazionale
Età da 18 a 80 · Tutti i sessi · Aggiornato il 26 giu 2026 · NCT06129240TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- University of California San Francisco, San Francisco
In reclutamentoStudio osservazionale
Fino a 24 anni · Tutti i sessi · Aggiornato il 22 giu 2026 · NCT04098445Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Keck School of Medicine of USC, Los Angeles
In reclutamentoFase 2
Età 40 e oltre · Tutti i sessi · Aggiornato il 12 nov 2025 · NCT05975983Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Los Angeles
- aTyr Investigative Site, San Diego
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 7 mag 2025 · NCT05892614Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
- University of California San Francisco, San Francisco
In reclutamentoStudio osservazionale
Età da 18 a 90 · Tutti i sessi · Aggiornato il 3 mag 2024 · NCT06397677Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.